European approval for Teva’s migraine drug Ajovy
The drug is a pre-filled syringe for the prophylaxis of migraine in adults who have at least four migraine days per month.
2nd April 2019
Latest news
NICE nod for breast cancer delay drug
Eli Lilly’s Verzenio has been recommended for use within the Cancer Drugs Fund by NICE.
2nd April 2019
AZ’s Selumetinib granted US Breakthrough Therapy Designation
The BTD is for the treatment of paediatric patients aged three years and older with neurofibromatosis type 1 (NF1).
2nd April 2019
Circassia’s COPD drug gets FDA approval
The approval is based on data from three Phase III studies, ACLIFORM, AUGMENT and AMPLIFY.
2nd April 2019
NHS prescribed nearly 70M antidepressants last year as rates double in a decade
The number dispensed last year was almost double the 36 million recorded a decade ago in 2008.
1st April 2019
FDA green light for Merck's Mavenclad
The drug is the first oral MS treatment to provide two years of proven efficacy with a maximum of 20 days of treatment.
1st April 2019
Novartis strengthens anti-inflammatory drugs portfolio with IFM Tre buy
The Swiss company will pay $310 million in upfront payments.
1st April 2019
FDA label expansion for UCB's Cimzia
The FDA has approved the drug for a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis.
1st April 2019
No-deal Brexit could mean temporary medicines export ban
The ABPI has warned that "there a range of things outside of our control".
1st April 2019
Bluebird’s Zynteglo kicks off first Amsterdam CHMP recommendations
The European Medicines Agency's CHMP positive opinions are sparse this time around.
1st April 2019
J&J submits sNDA for Invokana after premature end to clinical trial
If approved, the drug will be the only therapy in nearly 20 years to reduce the risk of end-stage kidney disease.
29th March 2019
Boots tests ‘behavioural nudge theory’ for medication adherence
The study found that patients warned of adverse consequences to their own health of skipping doses were more likely to adhere.
29th March 2019
NICE backs PredictImmune's IBD prognosis test
The CE-marked prognostic test for guiding treatment options uses a gene expression “signature”.
29th March 2019
BMS signs deal with Concerto HealthAI
The partnership will give the American pharma giant access to Concerto’s eurekaHealth AI insights platform.
29th March 2019
AstraZeneca and Daiichi sign $6.9bn cancer drug deal
The collaboration is aligned with AstraZeneca’s science-led strategy in oncology.
29th March 2019
